These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 15818636)

  • 1. Communicating safety information to physicians: an examination of dear doctor letters.
    Mazor KM; Andrade SE; Auger J; Fish L; Gurwitz JH
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):869-75. PubMed ID: 15818636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between physicians' perceptions and practices during pelvic examinations in Taiwan.
    Chen SL; Jane SW; Yu YM; Hsieh YS
    Patient Educ Couns; 2009 Jan; 74(1):124-9. PubMed ID: 18838242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the letters we write: an exploration of doctor-doctor communication in cancer care.
    McConnell D; Butow PN; Tattersall MH
    Br J Cancer; 1999 May; 80(3-4):427-37. PubMed ID: 10408849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peer assessment of outpatient consultation letters--feasibility and satisfaction.
    Keely E; Myers K; Dojeiji S; Campbell C
    BMC Med Educ; 2007 May; 7():13. PubMed ID: 17519024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of feedback letters to physicians and pharmacists on the appropriate use of medication in the treatment of asthma.
    Blais R; Laurier C; Paré M
    J Asthma; 2008 Apr; 45(3):227-31. PubMed ID: 18415831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cisapride label changes on codispensing of contraindicated medications.
    Guo JJ; Curkendall S; Jones JK; Fife D; Goehring E; She D
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):295-301. PubMed ID: 12812009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
    Goodwin J; Rieder S; Rieder MJ; Matsui D
    Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Referral letters to the pediatric emergency department].
    Edvardson S; Dor T
    Harefuah; 2008 Jul; 147(7):602-4, 663-4. PubMed ID: 18814518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.
    Willy ME; Li Z
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):201-6. PubMed ID: 15255086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the importance of the referral letter in the patient journey? A pilot survey in Western Australia.
    Jiwa M; Arnet H; Bulsara M; Ee HC; Harwood A
    Qual Prim Care; 2009; 17(1):31-6. PubMed ID: 19281672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' response to a letter to confirm diagnosis in a genetic study of psoriasis.
    Mahé E; Lahfa M; Mansouri S; Mosharraf-Olmolk H; Le Rebours J; Prud'Homme JF; Fischer J
    Eur J Dermatol; 2002; 12(1):66-9. PubMed ID: 11809599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use.
    Meadows WA; Hollowell BD
    Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences on patients' ratings of physicians: Physicians demographics and personality.
    Duberstein P; Meldrum S; Fiscella K; Shields CG; Epstein RM
    Patient Educ Couns; 2007 Feb; 65(2):270-4. PubMed ID: 17125958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unlicensed and off label usage of some drugs in obstetric practice].
    Bozhinova S; Tsvetkov D
    Akush Ginekol (Sofiia); 2008; 47(5):43-7. PubMed ID: 19227775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of patient-specific ratings vs conventional guidelines on investigation decisions in angina: Appropriateness of Referral and Investigation in Angina (ARIA) Trial.
    Junghans C; Feder G; Timmis AD; Eldridge S; Sekhri N; Black N; Shekelle P; Hemingway H
    Arch Intern Med; 2007 Jan; 167(2):195-202. PubMed ID: 17242322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labelling and 'Dear Doctor' letters: are they noncommittal?
    van Grootheest AC; Edwards IR
    Drug Saf; 2002; 25(15):1051-5. PubMed ID: 12452731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are physicians not persuaded by scientific evidence? A grounded theory interview study.
    Sekimoto M; Imanaka Y; Kitano N; Ishizaki T; Takahashi O
    BMC Health Serv Res; 2006 Jul; 6():92. PubMed ID: 16872522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.